Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) EBITDA (2019 - 2025)

Preaxia Health Care Payment Systems (PAXH) has disclosed EBITDA for 7 consecutive years, with -$874906.0 as the latest value for Q3 2025.

  • Quarterly EBITDA fell 18808.71% to -$874906.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$906662.0 through Aug 2025, down 1335.57% year-over-year, with the annual reading at -$79782.0 for FY2025, 19.78% up from the prior year.
  • EBITDA hit -$874906.0 in Q3 2025 for Preaxia Health Care Payment Systems, down from -$13463.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$4611.0 in Q2 2024 to a low of -$874906.0 in Q3 2025.
  • Historically, EBITDA has averaged -$79108.9 across 5 years, with a median of -$40317.0 in 2021.
  • Biggest five-year swings in EBITDA: soared 88.69% in 2024 and later crashed 18808.71% in 2025.
  • Year by year, EBITDA stood at -$43655.0 in 2021, then dropped by 3.29% to -$45092.0 in 2022, then decreased by 0.04% to -$45109.0 in 2023, then skyrocketed by 69.7% to -$13666.0 in 2024, then tumbled by 6302.06% to -$874906.0 in 2025.
  • Business Quant data shows EBITDA for PAXH at -$874906.0 in Q3 2025, -$13463.0 in Q1 2025, and -$13666.0 in Q4 2024.